Maxcyte (MXCT) Accumulated Depreciation (2020 - 2025)

Historic Accumulated Depreciation for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $17.0 million.

  • Maxcyte's Accumulated Depreciation rose 3459.07% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 3459.07%. This contributed to the annual value of $13.6 million for FY2024, which is 3214.08% up from last year.
  • Per Maxcyte's latest filing, its Accumulated Depreciation stood at $17.0 million for Q3 2025, which was up 3459.07% from $16.5 million recorded in Q2 2025.
  • Maxcyte's Accumulated Depreciation's 5-year high stood at $17.0 million during Q3 2025, with a 5-year trough of $3.6 million in Q2 2021.
  • Over the past 5 years, Maxcyte's median Accumulated Depreciation value was $8.7 million (recorded in 2023), while the average stood at $9.3 million.
  • Per our database at Business Quant, Maxcyte's Accumulated Depreciation soared by 6560.29% in 2023 and then soared by 3214.08% in 2024.
  • Over the past 5 years, Maxcyte's Accumulated Depreciation (Quarter) stood at $4.4 million in 2021, then surged by 43.51% to $6.3 million in 2022, then soared by 63.92% to $10.3 million in 2023, then soared by 32.14% to $13.6 million in 2024, then increased by 24.96% to $17.0 million in 2025.
  • Its Accumulated Depreciation was $17.0 million in Q3 2025, compared to $16.5 million in Q2 2025 and $15.6 million in Q1 2025.